Renoprotective Effect of Nisoldipine and Lisinopril in Type 1 Diabetic Nephropathy
Status:
Completed
Trial end date:
1999-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study was to compare the renoprotective effect of a long acting calcium
antagonist (nisoldipine) with an angiotensin converting enzyme inhibitor (lisinopril)in type
1 diabetic patients with diabetic kidney disease. In total, 51 patients were randomised to
treatment with one of these drugs for 4 years. Changes in kidney function, blood pressure and
urinary excretion of albumin were measured every 6 months
Phase:
Phase 4
Details
Lead Sponsor:
Steno Diabetes Center Steno Diabetes Center Copenhagen